Skip to main content
Clinical Trials/IRCT2015120320468N3
IRCT2015120320468N3CompletedPhase 2

Efficacy and side effects of Nd:YAG versus fractional Er:YAG in facial rejuvination

Skin Research Center, Shahid Beheshti University of Medical Science0 sites35 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
35

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
35 years to 75 years (—)
Sex
Female

Inclusion Criteria

  • females between 35 and 75years of age ;patients with mild to moderate facial rhytides at rest Exclusion criteria :males;females younger than 35 yerars old;pregnancy and lactatation;cosmetic procedures affecting the treatment area (e.g.,botulinum toxin,dermabrasion, chemical peeling, laser surgery, or face-lift)within the last 6months;oral isotretinoin within the last 6months; history of keloid formation,connective tissue disorders,major underlying disease,diabetes, uncontrolled hypertension, active infection in face area, personal history of skin cancer in face,unrealistic expectation,sensitivity to tetracaine or lidocaine

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Skin Research Center, Shahid Beheshti University of Medical Science

Similar Trials